Pharmafocus
Pharmaceutical Industry news, analysis and insights
The WHO has shared a medical product alert for an additional contaminated cough syrup medicine identified in Africa.
Astellas Pharma and Mitsui Fudosan have announced that Astellas plans to establish a tumour microenvironment (TME) open innovation hub, intended to open in October 2023.
GSK has announced that the FDA has approved Jemperli (dostarlimab) in combination with carboplatin and paclitaxel for the treatment of adult patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient (DMMR) or microsatellite instability-high (MSI-H).
FDA has announced that it has approved the Opill (norgestrel) tablet for non-prescription use to prevent pregnancy.
The FDA has announced that it has approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for the treatment of adult patients with type 1 diabetes.